{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:59:59Z","timestamp":1790935199222,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T00:00:00Z","timestamp":1129766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00296-005-0061-8","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T08:13:41Z","timestamp":1129709621000},"page":"732-740","source":"Crossref","is-referenced-by-count":11,"title":["The protective effects of incadronate on inflammation and joint destruction in established rat adjuvant arthritis"],"prefix":"10.1007","volume":"26","author":[{"given":"Hongpu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,10,20]]},"reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692\u20136","journal-title":"J Clin Invest"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/bmj.295.6609.1301","volume":"295","author":"HI Harinck","year":"1987","unstructured":"Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL (1987) Paget\u2019s disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J 295:1301\u20131305","journal-title":"Br Med J"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9343(88)80344-9","volume":"85","author":"D Thiebaud","year":"1988","unstructured":"Thiebaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P (1988) A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget\u2019s disease of bone. Am J Med 85:207\u2013212","journal-title":"Am J Med"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1586\/14737140.3.2.241","volume":"3","author":"JJ Body","year":"2003","unstructured":"Body JJ, Mancini I (2003) Treatment of tumor-induced hypercalcemia: a solved problem? Expert Rev Anticancer Ther 3:241\u2013246","journal-title":"Expert Rev Anticancer Ther"},{"issue":"Suppl","key":"61_CR5","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/1097-0142(20000615)88:12+<3054::AID-CNCR23>3.0.CO;2-Z","volume":"88","author":"JJ Body","year":"2000","unstructured":"Body JJ (2000) Current and future directions in medical therapy: hypercalcemia. Cancer 88(Suppl):3054\u20133058","journal-title":"Cancer"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265\u20131271","journal-title":"N Engl J Med"},{"key":"61_CR7","first-page":"2016","volume":"21","author":"F Eggelmeijer","year":"1994","unstructured":"Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BA, Breedveld FC (1994) Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. J Rheumatol 21:2016\u20132020","journal-title":"J Rheumatol"},{"key":"61_CR8","first-page":"2318","volume":"26","author":"FP Cantatore","year":"1999","unstructured":"Cantatore FP, Acquista CA, Pipitone V (1999) Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 26:2318\u20132323","journal-title":"J Rheumatol"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/17453677608992003","volume":"47","author":"T Havdrup","year":"1976","unstructured":"Havdrup T, Hulth A, Telhag H (1976) The subchondral bone in osteoarthritis and rheumatoid arthritis of the knee. A histological and microradiographical study. Acta Orthop Scand 47:345\u2013350","journal-title":"Acta Orthop Scand"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","volume":"27","author":"M Bromley","year":"1984","unstructured":"Bromley M, Woolley DE (1984) Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 27:968\u2013975","journal-title":"Arthritis Rheum"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.1780390307","volume":"39","author":"F Eggelmeijer","year":"1996","unstructured":"Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BA, Valkema R, Westedt ML, Landman JO, Pauwels EK, Breedveld FC (1996) Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial. Arthritis Rheum 39:396\u2013402","journal-title":"Arthritis Rheum"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/03009749409103063","volume":"23","author":"A Maccagno","year":"1994","unstructured":"Maccagno A, Di GE, Roldan EJ, Caballero LE, Perez LA (1994) Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis. Scand J Rheumatol 23:211\u2013214","journal-title":"Scand J Rheumatol"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.45.1.67","volume":"45","author":"A Barbier","year":"1986","unstructured":"Barbier A, Breliere JC, Remandet B, Roncucci R (1986) Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate. Ann Rheum Dis 45:67\u201374","journal-title":"Ann Rheum Dis"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00579699","volume":"14","author":"T Osterman","year":"1994","unstructured":"Osterman T, Kippo K, Lauren L, Hannuniemi R, Sellman R (1994) Effect of clodronate on established adjuvant arthritis. Rheumatol Int 14:139\u2013147","journal-title":"Rheumatol Int"},{"key":"61_CR15","first-page":"1972","volume":"26","author":"NV Podworny","year":"1999","unstructured":"Podworny NV, Kandel RA, Renlund RC, Grynpas MD (1999) Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis. J Rheumatol 26:1972\u20131982","journal-title":"J Rheumatol"},{"key":"61_CR16","first-page":"397","volume":"5","author":"H Zhao","year":"2000","unstructured":"Zhao H, Shuto T, Hirata G, Iwamoto Y (2000) Aminobisphosphonate (YM175) inhibits bone destruction in rat adjuvant arthritis. J Orthop Sci 5:397\u2013403","journal-title":"J Orthop Sci"},{"key":"61_CR17","first-page":"1280","volume":"30","author":"A Matsuo","year":"2003","unstructured":"Matsuo A, Shuto T, Hirata G, Satoh H, Matsumoto Y, Zhao H, Iwamoto Y (2003) Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis. J Rheumatol 30:1280\u20131290","journal-title":"J Rheumatol"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/art.1780381211","volume":"38","author":"RW Kinne","year":"1995","unstructured":"Kinne RW, Schmidt-Weber CB, Hoppe R, Buchner E, Palombo-Kinne E, Nurnberg E, Emmrich F (1995) Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. Arthritis Rheum 38:1777\u20131790","journal-title":"Arthritis Rheum"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/8756-3282(95)00426-2","volume":"18","author":"M Nishikawa","year":"1996","unstructured":"Nishikawa M, Akatsu T, Katayama Y, Yasutomo Y, Kado S, Kugal N, Yamamoto M, Nagata N (1996) Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18:9\u201314","journal-title":"Bone"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1359\/jbmr.1998.13.6.986","volume":"Res13","author":"M Nishikawa","year":"1998","unstructured":"Nishikawa M, Yamamoto M, Murakami T, Akatsu T, Kugai N, Nagata N (1998) A third-generation bisphosphonate, YM175, inhibits osteoclast formation in murine cocultures by inhibiting proliferation of precursor cells via supporting cell-dependent mechanisms. J Bone Miner Res13:986\u2013995","journal-title":"J Bone Miner"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S8756-3282(99)00197-0","volume":"25","author":"M Ito","year":"1999","unstructured":"Ito M, Amizuka N, Nakajima T, Ozawa H (1999) Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 25:447\u2013452","journal-title":"Bone"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.61.6.530","volume":"61","author":"HJ Lehmann","year":"2002","unstructured":"Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C (2002) Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 61:530\u2013533","journal-title":"Ann Rheum Dis"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S8756-3282(01)00431-8","volume":"28","author":"P Garnero","year":"2001","unstructured":"Garnero P, Christgau S, Delmas PD (2001) The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget\u2019s disease of bone. Bone 28:461\u2013464","journal-title":"Bone"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1749-6632.1999.tb07702.x","volume":"878","author":"O Teronen","year":"1999","unstructured":"Teronen O, Heikkila P, Konttinen YT, Laitinen M, Salo T, Hanemaaijer R, Teronen A, Maisi P, Sorsa T (1999) MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 878:453\u2013465","journal-title":"Ann N Y Acad Sci"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/ard.61.10.925","volume":"61","author":"JF Offel Van","year":"2002","unstructured":"Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS (2002) Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 61:925\u2013928","journal-title":"Ann Rheum Dis"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0008-8749(86)90067-5","volume":"103","author":"WJ Johnson","year":"1986","unstructured":"Johnson WJ, DiMartino MJ, Hanna N (1986) Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activation. Cell Immunol 103:54\u201364","journal-title":"Cell Immunol"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581\u2013589","journal-title":"J Bone Miner Res"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1476-5381.1996.tb15972.x","volume":"119","author":"M Nakamura","year":"1996","unstructured":"Nakamura M, Ando T, Abe M, Kumagai K, Endo Y (1996) Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br J Pharmacol 119:205\u2013212","journal-title":"Br J Pharmacol"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524\u2013531","journal-title":"Bone"},{"key":"61_CR30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"61_CR31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1359\/jbmr.2003.18.3.512","volume":"18","author":"S Komatsubara","year":"2003","unstructured":"Komatsubara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanishi J, Norimatsu H (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18:512\u2013520","journal-title":"J Bone Miner Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0061-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0061-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0061-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:15:20Z","timestamp":1559027720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0061-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,20]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0061-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,20]]}}}